-
AstraZeneca, Biopharma Giant, Announces $2bn Investment in Maryland
28 Nov 2025 02:24 GMT
… home when it comes to AstraZeneca, the British drugmaker. On November … AZ.
Pascal Soriot, the AZ CEO, jokingly said that he hoped …
-
AstraZeneca Shares Soar 7% as Pharma Giant Unveils Breakthrough Cancer Drug Data
27 Nov 2025 08:32 GMT
… breast cancer, which strengthens AstraZeneca’s pipeline, which is … Pharma Boom Accelerates as AstraZeneca Leads Charge on Biotech Breakthroughs …
The AstraZeneca momentum effect spread out … is a legacy of CEO Pascal Soriot. In an …
-
UK pharma giant AstraZeneca invest $2bn in Maryland manufacturing facility
26 Nov 2025 21:48 GMT
… week, UK-based pharmaceutical conglomerate AstraZeneca announced a further $2 billion … to partner with AstraZeneca to grow our economy.”
AstraZeneca claims the investment … for the first time,” commented AstraZeneca CEO Pascal Soriot.
Related:Leading Ohio …
-
AstraZeneca to Invest $2 Billion in Maryland Manufacturing Hub
25 Nov 2025 19:54 GMT
… time, allow production of AstraZeneca’s rare disease drugs … to high environmental standards.
“AstraZeneca's commitment to … and American patients,” added AstraZeneca CEO Pascal Soriot. “As the … of its Virginia facility.
AstraZeneca has pledged $50 billion …
-
AstraZeneca furthers US manufacturing commitment with $2bn Maryland investment
25 Nov 2025 17:09 GMT
… The current investment will expand AstraZeneca’s flagship biologics manufacturing facility … pharma jobs, according to AstraZeneca.
Both manufacturing facilities in … data analytics.
Pascal Soriot, Chief Executive Officer, AstraZeneca, explained that its $2 …
-
AstraZeneca Plans $2 Billion Biomanufacturing Investment in Maryland
25 Nov 2025 16:10 GMT
… in 2029.
In parallel, AstraZeneca will build a new … patients,” noted Pascal Soriot, CEO, AstraZeneca. “As the state’s … s announcement is part of AstraZeneca’s $50 billion investment … the country. In 2025, AstraZeneca created approximately $20 billion of …
-
AstraZeneca to Invest $2 Billion in Major Maryland Expansion
25 Nov 2025 11:24 GMT
… currently produces biologics used across AstraZeneca’s portfolio of cancer, autoimmune … also to manufacture products from AstraZeneca’s rare disease portfolio … for all.”
Pascal Soriot, AstraZeneca’s Chief Executive Officer, emphasized the broader national …
-
Harbour BioMed advances global strategic collaboration with AstraZeneca to discover and develop next-generation biotherapeutics in oncology
25 Nov 2025 10:20 GMT
… its global strategic collaboration with AstraZeneca, originally established in March 2025 … . Jingsong Wang, founder, chairman and CEO of Harbour BioMed, said: “We … to advance our collaboration with AstraZeneca to develop next-generation biotherapeutics …
-
AstraZeneca Maryland Investment: $2 Billion Expansion Brings 2,600 Jobs to Frederick, Gaithersburg
25 Nov 2025 07:35 GMT
… County, Maryland at the Astrazeneca event
AstraZeneca’s Broader U.S. … highest environmental standards, reflecting AstraZeneca’s commitment to sustainable manufacturing … I-270 Technology Corridor.”
AstraZeneca Chief Executive Officer Pascal Soriot framed the …
-
AstraZeneca commits $2B to Maryland manufacturing expansion
25 Nov 2025 02:49 GMT
… approximately 2,600 jobs,” CEO Pascal Soriot said at … continues
Last month, AstraZeneca broke ground on a new … produce drug substances for AstraZeneca’s weight management and … unsuccessfully lobbied to “get AstraZeneca’s continued expansion.” Moore …